Psychiatry Research

• 

  Publication Venue For

  • Associations between neuropsychiatric and health status outcomes in individuals with probable mTBI..  272:531-539. 2019
  • Exploration of NO2 and PM2.5 air pollution and mental health problems using high-resolution data in London-based children from a UK longitudinal cohort study..  272:8-17. 2019
  • Why do trauma survivors become depressed? Testing the behavioral model of depression in a nationally representative sample..  272:587-594. 2019
  • Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes. 2019
  • Six-year outcome for children with ODD or CD treated with the coping power program..  271:454-458. 2019
  • A genome-wide association study of suicide attempts and suicidal ideation in U.S. military veterans..  269:64-69. 2018
  • Self- and parent-reported depressive symptoms rated by the mood and feelings questionnaire..  268:419-425. 2018
  • Maintenance ECT in schizophrenia: A systematic review..  264:131-142. 2018
  • Characterizing anger-related affect in individuals with posttraumatic stress disorder using ecological momentary assessment..  261:274-280. 2018
  • The association of alcohol consumption patterns with self-rated physical health and psychiatric distress among Afghanistan- and Iraq-era U.S. veterans..  259:142-147. 2018
  • Paternal history of mental illness associated with posttraumatic stress disorder among veterans..  256:461-468. 2017
  • ADHD and nonsuicidal self-injury in male veterans with and without PTSD..  252:161-163. 2017
  • Differences in psychiatric symptoms and barriers to mental health care between volunteer and career firefighters..  247:236-242. 2017
  • Nonsuicidal self-injury and interpersonal violence in U.S. veterans seeking help for posttraumatic stress disorder..  247:250-256. 2017
  • A longitudinal analysis of the overlap between violence and victimization among adults with mental illnesses..  246:203-210. 2016
  • The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18..  245:83-90. 2016
  • Does body mass index moderate the association between posttraumatic stress disorder symptoms and suicidal ideation in Iraq/Afghanistan veterans?.  244:123-129. 2016
  • A 12-Month prospective study of the effects of PTSD-depression comorbidity on suicidal behavior in Iraq/Afghanistan-era veterans..  243:97-99. 2016
  • Nonsuicidal self-injury and suicide attempts in Iraq/Afghanistan war veterans..  243:232-237. 2016
  • Sexual revictimization among Iraq and Afghanistan war era veterans..  240:406-411. 2016
  • Comorbidity and quality of life in adults with hair pulling disorder..  239:12-19. 2016
  • Callous unemotional traits in children with disruptive behavior disorder: Predictors of developmental trajectories and adolescent outcomes..  236:35-41. 2016
  • Neuropsychological profile in adult schizophrenia measured with the CMINDS..  230:826-834. 2015
  • The fMRI BOLD response to unisensory and multisensory smoking cues in nicotine-dependent adults..  234:321-327. 2015
  • Validity and reliability analysis of the Chinese parent version of the Autism Spectrum Rating Scale (6-18 years)..  230:255-261. 2015
  • Non-suicidal self-injury with and without borderline personality disorder: differences in self-injury and diagnostic comorbidity..  230:28-35. 2015
  • Does military sexual trauma moderate the impact of critical warzone experiences?.  229:596-598. 2015
  • Effect of genetic variation in the nicotinic receptor genes on risk for posttraumatic stress disorder..  229:326-331. 2015
  • Internal consistency, test-retest reliability, and predictive validity for a Likert-based version of the Sources of occupational stress-14 (SOOS-14) scale..  228:961-962. 2015
  • Non-suicidal self-injury as a predictor of active and passive suicidal ideation among Iraq/Afghanistan war veterans..  227:360-362. 2015
  • An examination of the broader effects of warzone experiences on returning Iraq/Afghanistan veterans' psychiatric health..  226:78-83. 2015
  • An examination of the broader effects of warzone experiences on returning Iraq/Afghanistan veterans' psychiatric health.  226:78-83. 2015
  • Speed of response to electroconvulsive therapy compared with ketamine..  225:215. 2015
  • Measuring the role of psychological inflexibility in Trichotillomania.  220:356-361. 2014
  • Measuring the role of psychological inflexibility in Trichotillomania..  220:356-361. 2014
  • Smoking automaticity and tolerance moderate brain activation during explore-exploit behavior..  224:254-261. 2014
  • The critical warzone experiences (CWE) scale: initial psychometric properties and association with PTSD, anxiety, and depression..  220:1118-1124. 2014
  • The factor structure of psychiatric comorbidity among Iraq/Afghanistan-era veterans and its relationship to violence, incarceration, suicide attempts, and suicidality..  220:397-403. 2014
  • Efficacy of a multimodal treatment for disruptive behavior disorders in children and adolescents: Focus on internalizing problems.  219:617-624. 2014
  • Efficacy of a multimodal treatment for disruptive behavior disorders in children and adolescents: focus on internalizing problems..  219:617-624. 2014
  • Assessing blinding in trials of psychiatric disorders: a meta-analysis based on blinding index..  219:241-247. 2014
  • Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis..  218:39-43. 2014
  • The impact of social support on psychological distress for U.S. Afghanistan/Iraq era veterans with PTSD and other psychiatric diagnoses.  217:86-92. 2014
  • Orbitofrontal cortex volume and intrinsic religiosity in non-clinical psychosis..  222:124-130. 2014
  • The impact of social support on psychological distress for U.S. Afghanistan/Iraq era veterans with PTSD and other psychiatric diagnoses..  217:86-92. 2014
  • Combined PTSD and depressive symptoms interact with post-deployment social support to predict suicidal ideation in Operation Enduring Freedom and Operation Iraqi Freedom veterans..  216:357-362. 2014
  • A multi-scanner study of subcortical brain volume abnormalities in schizophrenia..  222:10-16. 2014
  • Acute effects of trauma-focused research procedures on participant safety and distress.  215:154-158. 2014
  • Acute effects of trauma-focused research procedures on participant safety and distress..  215:154-158. 2014
  • Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis.  218:39-43. 2014
  • The factor structure of psychiatric comorbidity among Iraq/Afghanistan-era veterans and its relationship to violence, incarceration, suicide attempts, and suicidality.  220:397-403. 2014
  • Modulation of motor cortex excitability in obsessive-compulsive disorder: An exploratory study on the relations of neurophysiology measures with clinical outcome.  210:1026-1032. 2013
  • Modulation of motor cortex excitability in obsessive-compulsive disorder: an exploratory study on the relations of neurophysiology measures with clinical outcome..  210:1026-1032. 2013
  • Hypothalamic-pituitary-adrenal axis dysfunction in non-clinical psychosis..  206:315-317. 2013
  • Hypothalamic-pituitary-adrenal axis dysfunction in non-clinical psychosis 2013
  • Assessment of gene expression in peripheral blood using RNAseq before and after weight restoration in anorexia nervosa.  210:287-293. 2013
  • Case-control association study of 36 single-nucleotide polymorphisms within 10 candidate genes for major depression and bipolar disorder.  209:121-123. 2013
  • Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): Sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.  205:67-73. 2013
  • Assessing illicit drug use among adults with schizophrenia..  200:228-236. 2012
  • Sleep impairment, mood symptoms, and psychosocial functioning in adolescent bipolar disorder..  200:265-271. 2012
  • Genetic association study of individual symptoms in depression..  198:400-406. 2012
  • AGTR1 gene variation: association with depression and frontotemporal morphology..  202:104-109. 2012
  • Assessing illicit drug use among adults with schizophrenia.  200:228-236. 2012
  • Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): Sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder 2012
  • The course of cognitive functioning over six months in individuals at clinical high risk for psychosis 2012
  • Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia 2012
  • Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia.  200:835-842. 2012
  • Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards..  194:263-270. 2011
  • Reduced amygdala-orbitofrontal connectivity during moral judgments in youths with disruptive behavior disorders and psychopathic traits..  194:279-286. 2011
  • Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia..  189:26-32. 2011
  • Reduction of dorsolateral prefrontal cortex gray matter in late-life depression..  193:1-6. 2011
  • fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence..  192:167-175. 2011
  • Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis..  187:42-48. 2011
  • Temporo-parietal junction stimulation in the treatment of depersonalization disorder.  186:138-140. 2011
  • TAAR6 variations possibly associated with antidepressant response and suicidal behavior..  180:20-24. 2010
  • COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome..  178:433-436. 2010
  • Clinical utility of the Primary Care--PTSD Screen among U.S. veterans who served since September 11, 2001..  178:330-335. 2010
  • Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome..  181:1-8. 2010
  • The Schizophrenia cognition Rating Scale: Validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia.  178:33-38. 2010
  • Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression..  172:49-54. 2009
  • Alterations in the neural circuitry for emotion and attention associated with posttraumatic stress symptomatology..  172:7-15. 2009
  • Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder..  172:61-67. 2009
  • Atypical modulation of cognitive control by arousal in autism..  164:185-197. 2008
  • Statistical procedures for analyzing mental health services data..  160:129-136. 2008
  • Hippocampal volumes and depression subtypes..  163:126-132. 2008
  • Prefrontal mechanisms for executive control over emotional distraction are altered in major depression..  163:143-155. 2008
  • Age-dependent reduction of amygdala volume in bipolar disorder..  163:84-94. 2008
  • Modification effects of coping on post-traumatic morbidity among earthquake rescuers.  158:164-171. 2008
  • Neural systems for executive and emotional processing are modulated by symptoms of posttraumatic stress disorder in Iraq War veterans..  162:59-72. 2008
  • Symptoms of neurasthenia following earthquake trauma: re-examination of a discarded syndrome..  153:171-177. 2007
  • Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia..  153:77-81. 2007
  • Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders..  153:83-86. 2007
  • An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials..  152:293-297. 2007
  • The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults..  155:173-177. 2007
  • Perceived stress in anxiety disorders and the general population: A study of the Sheehan stress vulnerability scale.  151:249-254. 2007
  • Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms..  145:215-223. 2006
  • Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls..  144:99-108. 2006
  • Differences in brain volumes among males and female hormone-therapy users and nonusers..  147:127-134. 2006
  • Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder..  142:99-104. 2006
  • Probing reward function in post-traumatic stress disorder with beautiful facial images..  135:179-183. 2005
  • Greater MRI lesion volumes in elderly depressed subjects than in control subjects..  139:1-7. 2005
  • Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography..  116:173-185. 2002
  • Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects..  115:63-77. 2002
  • MR signal intensity of gray matter/white matter contrast and intracranial fat: effects of age and sex..  114:149-161. 2002
  • Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals..  110:103-115. 2002
  • Evidence for altered cerebellar vermis neuronal integrity in schizophrenia..  107:125-134. 2001
  • Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder..  88:63-70. 1999
  • Clinical, demographic and social characteristics of psychotic depression..  86:99-106. 1999
  • Magnetic-resonance morphometry in patients with major depression..  84:7-15. 1998
  • Magnetic resonance imaging signal hypointensity and iron content of putamen nuclei in elderly depressed patients..  83:95-103. 1998
  • Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy..  82:95-106. 1998
  • Psychosocial and physical correlates of chronic depression..  72:149-159. 1997
  • Intracranial and extracranial blood flow during acute anxiety..  74:93-107. 1997
  • Lifetime comorbidity, lifetime history of psychosis and suicide attempts, and current symptoms of patients with deteriorated affective disorder.  73:33-45. 1997
  • Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness.  73:109-113. 1997
  • Magnetic resonance imaging changes in putamen nuclei iron content and distribution in normal subjects..  68:55-61. 1996
  • Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method..  67:215-234. 1996
  • Effect of ECT treatment number on the ictal EEG..  62:179-189. 1996
  • Information-processing markers of vulnerability to schizophrenia: Performance of patients with schizotypal and nonschizotypal personality disorders.  60:49-56. 1996
  • MRI changes in schizophrenia in late life: A preliminary controlled study.  60:117-123. 1996
  • Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder..  59:127-136. 1995
  • Geniculocalcarine hyperintensities on brain magnetic resonance imaging associated with visual hallucinations in the elderly..  54:283-293. 1994
  • Ipsilateral subcortical atrophy associated with temporal lobectomy..  54:295-304. 1994
  • Relative accuracy and reproducibility of regional MRI brain volumes for point-counting methods..  55:167-177. 1994
  • Magnetic resonance imaging in social phobia..  52:35-42. 1994
  • No association between alleles or genotypes at the dopamine transporter gene and schizophrenia..  52:17-23. 1994
  • Effects of marijuana on performance of a computerized cognitive-neuromotor test battery..  51:115-125. 1994
  • Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests.  53:1-12. 1994
  • Hypercortisolemia and hippocampal changes in depression..  47:163-173. 1993
  • Empirical assessment of the factorial structure of clinical symptoms in schizophrenic patients: formal thought disorder..  44:141-151. 1992
  • In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients..  44:63-70. 1992
  • Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: Negative symptoms.  44:153-165. 1992
  • A magnetic resonance imaging study of putamen nuclei in major depression.  40:95-99. 1991
  • Occurrence of subcortical hyperintensities in elderly subjects with mania..  40:211-220. 1991
  • A magnetic resonance imaging study of putamen nuclei in major depression..  40:95-99. 1991
  • Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow..  40:125-134. 1991
  • Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients.  38:285-292. 1991
  • Effects of bright light on responsiveness to a muscarinic agonist in rats selectively bred for endogenously increased cholinergic function..  33:139-150. 1990
  • Attentional markers of vulnerability to schizophrenia: Performance of medicated and unmedicated patients and normals.  33:179-188. 1990
  • Comparison of early and delayed inpatient dexamethasone suppression tests..  27:161-171. 1989
  • Letter. Cerebral blood flow responses to CO₂ and acetazolamide: The effect of anxiety.  28:241-242. 1989
  • Cerebral blood flow changes induced by CO2 in anxiety..  23:285-294. 1988
  • A comparative evaluation of three discriminant scales for endogenous depression..  23:193-200. 1988
  • Behavioral indications for serotonin receptor hypersensitivity in panic disorder.  25:101-104. 1988
  • Forms of atypical depression and their response to antidepressant drugs..  17:87-95. 1986
  • Cortisol escape from morphine suppression..  15:91-95. 1985
  • Platelet alpha 2-adrenergic receptors in schizophrenic patients before and after phenothiazine treatment..  12:69-77. 1984
  • Urinary excretion of biopterin and neopterin in psychiatric disorders..  11:83-89. 1984
  • Inferential statistical methods for strengthening the interpretation of laboratory test results..  10:207-216. 1983
  • Dissociation of TSH adrenocortical disturbances in endogenous depression..  3:253-264. 1980
  • Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression..  2:251-258. 1980
  • Research issues in psychological studies of chronic dialysis.  3:307-314. 1980